कोरोना वायरस (Coronavirus) के नए और अधिक संक्रामक वेरिएंट ओमिक्रॉन (Omicron) के सामने आने के बाद ब्रिटेन में हालात बिगड़ते जा रहे हैं. ओमिक्रॉन के मामलों में तेज वृद्धि के बीच ब्रिटेन में रोजाना आने वाले नए मामलों की संख्या 1 लाख के पार निकल गई है. ब्रिटेन में पहली बार कोरोना के दैनिक मामले […]
Read MoreBy Administrator_India Capital Sands Export of COVID-19 vaccines can start in about next two weeks, the Business Standard reported, quoting Serum Institute of India (SII)’s Chief Executive Officer (CEO) Adar Poonawalla. The news report further cites Poonawalla as saying that exports of the vaccine doses will start only after local requirements are fully met. Further, the […]
Read MoreBy Administrator_India Capital Sands India’s drug regulator on Sunday gave its final approval to the Oxford-AstraZeneca and Bharat Biotech coronavirus vaccines for restricted use in an emergency situation, giving the country its first two shots for immunising its vast population in the coming weeks. While the Oxford-AstraZeneca vaccine, manufactured by Serum Institute of India (SII), has 70.42 per cent efficacy, the indigenous […]
Read MoreBy Administrator_India Capital Sands Britain must vaccinate two million people a week to avoid a third wave of the coronavirus outbreak, a study by the London School of Hygiene and Tropical Medicine (LSHTM) has concluded. The UK has had more than 71,000 deaths from the coronavirus and has recorded over 2.3 million cases of COVID-19 […]
Read MoreBy Administrator_India capital Sands Britain will be the first country in the West to roll out a Covid-19 vaccine, beating the United States and Europe in a race to control the pandemic that has left close to 1.5 million dead globally. UK’s drug authority—Medicines and Healthcare products Regulatory Agency (MHRA)–on Wednesday granted an emergency licence […]
Read MoreBy Administrator_India Capital Sands Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely-watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects. Whether any of these efforts will result in a vaccine capable […]
Read MoreBy Administrator_India Capital Sands Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash. In the meantime, the firm’s chief executive is pocketing millions of dollars every month by selling shares […]
Read More